Financial Advocates Investment Management Ark Genomic Revolution ETF (De Transaction History
Financial Advocates Investment Management
- $1.37 Billion
- Q1 2025
A detailed history of Financial Advocates Investment Management transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Financial Advocates Investment Management holds 34,896 shares of ARKG stock, worth $722,696. This represents 0.05% of its overall portfolio holdings.
Number of Shares
34,896Holding current value
$722,696% of portfolio
0.05%Shares
10 transactions
Others Institutions Holding ARKG
# of Institutions
278Shares Held
20.9MCall Options Held
4.66MPut Options Held
3.85M-
Jpmorgan Chase & CO New York, NY3.43MShares$71.1 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.29MShares$68.1 Million0.01% of portfolio
-
Citigroup Inc2.56MShares$53 Million0.03% of portfolio
-
Morgan Stanley New York, NY2.37MShares$49 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.2MShares$25 Million0.0% of portfolio